June 30, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
AGA’s recent white paper provides a framework to navigate the latest innovations in obesity care, including GLP-1 receptor agonists, personalized treatment plans and endoscopic, bariatric and metabolic therapies.The new commentary is a follow up to AGA’s 2017 publication, “POWER: Practice Guide on Obesity and Weight Management, Education, and Resources,” and encourages
June 30, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Find the latest Primary Care and Obesity news articles, videos, podcasts, and meeting coverage from medical experts and key…

Lifestyle intervention remains a core component of obesity management, alongside the emergence of more potent pharmacotherapy.The…

GLP-1 receptor agonists are best known for treating type 2 diabetes and obesity, yet a growing body of evidence suggests their…

SAN DIEGO — GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand…

The latest obesity drug updates, research and clinical insights, from GLP-1 receptor agonists to new drugs in the pipeline.

ACP has published living clinical guidance to help physicians select medications for patients with overweight or…